+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Nizatidine"

From
Gastric Ulcers Market Report 2025 - Product Thumbnail Image

Gastric Ulcers Market Report 2025

  • Report
  • April 2025
  • 200 Pages
  • Global
From
Duodenal Ulcer Treatment Market Report 2025 - Product Thumbnail Image

Duodenal Ulcer Treatment Market Report 2025

  • Report
  • April 2025
  • 200 Pages
  • Global
From
Gastroesophageal Reflux Disease (GERD) Market Report 2025 - Product Thumbnail Image

Gastroesophageal Reflux Disease (GERD) Market Report 2025

  • Report
  • March 2025
  • 200 Pages
  • Global
From
Antacids Market Report 2025 - Product Thumbnail Image

Antacids Market Report 2025

  • Report
  • March 2025
  • 175 Pages
  • Global
From
From
  • 7 Results (Page 1 of 1)
Loading Indicator

Nizatidine is a medication used to treat gastrointestinal disorders, such as acid reflux and peptic ulcers. It is a histamine H2-receptor antagonist, which works by blocking the action of histamine on the cells in the stomach, reducing the production of stomach acid. It is available in both prescription and over-the-counter forms. Nizatidine is used to treat a variety of gastrointestinal disorders, including gastroesophageal reflux disease (GERD), peptic ulcers, and Zollinger-Ellison syndrome. It is also used to prevent and treat ulcers caused by the use of nonsteroidal anti-inflammatory drugs (NSAIDs). It is generally well-tolerated, with few side effects. Nizatidine is available in a variety of forms, including tablets, capsules, and oral suspensions. It is marketed by several pharmaceutical companies, including Pfizer, GlaxoSmithKline, and Merck. It is also available in generic forms. In the Nizatidine market, companies such as Pfizer, GlaxoSmithKline, and Merck are major players. Other companies include Mylan, Teva Pharmaceuticals, and Sun Pharmaceuticals. Show Less Read more